Market Tracker

07/28 4:45pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

32.07
Delayed Data
As of Jul 28
 -0.42 / -1.29%
Today’s Change
28.82
Today|||52-Week Range
46.24
-25.70%
Year-to-Date
Here's Why Myriad Genetics Is Down 26% in 2016
Jul 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close32.49
Today’s open32.40
Day’s range32.02 - 32.54
Volume391,778
Average volume (3 months)897,651
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)-52.00%
Earnings growth (this year)+13.47%
Earnings growth (next 5 years)+14.05%
Revenue growth (last year)-7.08%
P/E ratio21.7
Price/Sales3.50
Price/Book3.38

Competitors

 Today’s
change
Today’s
% change
NEOGNeogen Corp-0.11-0.20%
ALRAlere Inc+5.09+16.17%
AAAPAdvanced Accelerator...+0.02+0.06%
AMAGAMAG Pharmaceuticals...-0.31-1.15%
Data as of 4:02pm ET, 07/28/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)$0.37
Annual revenue (last year)$723.1M
Annual profit (last year)$80.2M
Net profit margin11.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts